Emergence of Clinical \i Escherichia coli\i0 Isolates with Decreased Susceptibility to Ceftazimide and Synergistic Effect with Co-Amoxiclav Due to SHV-1 Hyperproduction

E. Miró; M. del Cuerpo; F. Navarro; M. Sabate; B. Mirelis; G. Prats

Emergence of Clinical \i Escherichia coli\i0 Isolates with Decreased Susceptibility to Ceftazimide and Synergistic Effect with Co-Amoxiclav Due to SHV-1 Hyperproduction

E. Miró, M. del Cuerpo, F. Navarro, M. Sabate, B. Mirelis, G. Prats

Department of Genetics and Microbiology

Research output: Contribution to journal › Article › Research

Original language	English
Pages (from-to)	535-538
Journal	J. Antimicrobial Chemother.
Volume	42
Issue number	0
Publication status	Published - 1 Jan 1998

Cite this

@article{e53bfc102e2b4e2888cf9224fd7f8c1e,

title = "Emergence of Clinical \i Escherichia coli\i0 Isolates with Decreased Susceptibility to Ceftazimide and Synergistic Effect with Co-Amoxiclav Due to SHV-1 Hyperproduction",

author = "E. Mir{\'o} and {del Cuerpo}, M. and F. Navarro and M. Sabate and B. Mirelis and G. Prats",

year = "1998",

month = jan,

day = "1",

language = "English",

volume = "42",

pages = "535--538",

number = "0",

}